CARE Ratings has upgraded GHCL Textiles' long-term rating to 'CARE A; Stable' and short-term rating to 'CARE A1'. The upgrade covers bank facilities totaling Rs 600 crore and is based on the company's H1FY26 financial and operational performance. Notably, the company has also fully repaid certain term loans, leading to the withdrawal of those specific ratings. This improvement in credit profile suggests better financial stability and potential for reduced borrowing costs in the future.

Fortis Healthcare's wholly-owned subsidiary, International Hospital Limited (IHL), has successfully completed the acquisition of TMI Healthcare Private Limited. The transaction includes the hospital's operations along with the underlying land, building, and adjacent land parcels. This follows the definitive agreements previously entered into on December 20, 2025. The completion of this deal signifies Fortis's continued focus on expanding its physical infrastructure and service capacity.

Vinati Organics Limited has announced an additional investment of ₹31.19 Crore in its wholly-owned subsidiary, Veeral Organics Private Limited (VOPL). The company subscribed to 3,11,90,000 equity shares at a face value of ₹10 each through a rights issue. VOPL is engaged in manufacturing organic fine specialty chemicals, which is directly aligned with Vinati Organics' core business. This capital infusion is expected to support the subsidiary's growth and manufacturing capabilities.

Prestige Group, through its joint venture Canopy Living LLP, has signed an agreement to purchase a 16.38-acre land parcel in Padi, Chennai. The land is strategically located near Anna Nagar, a prime residential micro-market known for high demand and mature infrastructure. This acquisition is a joint venture with Arihant Foundations & Housing Limited, aimed at strengthening Prestige's residential pipeline in South India. As of September 2025, the group maintains a massive pipeline of 130 projects covering 199 million square feet.

Fortis Healthcare has outlined an aggressive expansion strategy to add over 3,200 beds by FY30, aiming for a total capacity of 8,061 beds. The company reported strong financial performance with H1FY26 consolidated revenue at INR 44,982 Mn and a significantly improved operating EBITDA margin of 23.3%. Hospital ARPOB grew 4.2% YoY to INR 24.9 Mn in H1FY26, while the diagnostics business maintained a healthy 24.6% margin. Key corporate milestones include the closure of the IHH Open Offer and the strategic acquisition of the 'Fortis' and 'SRL' brands.

Titan Company reported a robust 40% YoY growth in its domestic consumer businesses for Q3 FY26, led by a 41% surge in the jewellery segment. While jewellery revenue was significantly boosted by higher Average Selling Prices (ASP), buyer growth remained flattish, though gold coin sales nearly doubled. The watches division grew 13% YoY as strong analog sales offset a 26% decline in smartwatches, while international operations saw a massive 79% growth. The company also strategically entered the lab-grown diamond market with the launch of its new brand 'beYon'.

Shakti Pumps (India) Limited has announced a ₹3 Crore investment in its wholly-owned subsidiary, Shakti Energy Solutions Limited (SESL). This capital is earmarked for setting up a greenfield manufacturing plant for Solar DCR cells and Solar PV modules with a significant 2.20 GW capacity in Pithampur, Madhya Pradesh. SESL has demonstrated robust financial performance, with turnover rising from ₹99.15 Crores in FY23 to ₹216.53 Crores in FY25. This expansion signifies the company's aggressive push into the solar energy infrastructure segment and backward integration.

Infomerics has upgraded Pashupati Cotspin's long-term credit rating to IVR BBB-/Stable and short-term rating to IVR A3. The upgrade is primarily driven by a significant improvement in the company's capital structure, with the overall gearing ratio dropping from 2.56x in FY24 to 0.85x in FY25. While FY25 revenue saw a marginal decline of 2.14% to Rs 646.96 crore, the PAT margin improved from 1.24% to 1.98%. The company maintains adequate liquidity with gross cash accruals of Rs 26 crore against debt repayments of Rs 23.22 crore.

Tirupati Forge Limited has approved the allotment of 12,50,000 equity shares to a member of the promoter group following the exercise of convertible warrants. The conversion occurred at a price of Rs. 32 per share, resulting in a fresh capital infusion of Rs. 3 crore (representing the balance 75% payment). This move increases the specific promoter's stake from 13.36% to 14.22%. To date, the company has converted 72,50,000 warrants out of the 1,17,60,000 warrants originally issued in January 2025.

Tirupati Forge Limited has approved the allotment of 12,50,000 equity shares to a promoter group member, Chetna Mukeshbhai Thumar, following the conversion of warrants. The shares were issued at Rs. 32 each, including a premium of Rs. 30, resulting in a capital infusion of Rs. 3 crore (the 75% balance payment). This conversion increases the specific promoter's stake from 13.36% to 14.22%. So far, 72.5 lakh warrants out of the original 1.17 crore issued in January 2025 have been converted into equity.

CRISIL has reaffirmed Fortis Healthcare's long-term rating at 'AA+/Stable' and short-term rating at 'A1+', reflecting a strong business risk profile and improved operating efficiency. The company reported a 17% YoY revenue growth in H1 FY26 to ₹4,498 crore, with consolidated EBITDA margins expanding by 300 bps to 23.3%. Fortis is executing an aggressive expansion strategy, planning to add 1,200-1,500 beds by FY28, primarily through brownfield projects. Despite recent acquisitions like TMI Healthcare for ₹430 crore, the financial risk profile remains healthy with net debt/EBITDA projected to stay below 1.5x.

CRISIL has reaffirmed Fortis Healthcare’s long-term rating at 'AA+/Stable', following a previous upgrade in September 2025. The company reported a strong H1 FY26 with revenue growing 17% YoY to ₹4,498 crore and EBITDA margins expanding to 23.3%. Fortis is executing an aggressive expansion plan to add 1,200-1,500 beds by FY28, supported by recent acquisitions like Shrimann Superspecialty and TMI Healthcare. Despite rising debt levels to approximately ₹3,400-3,500 crore for these acquisitions, the financial risk profile remains robust with gearing expected to stay below 0.6x.

Satin Creditcare Network Limited has approved the issuance of senior, secured, rated, and listed Non-Convertible Debentures (NCDs) on a private placement basis. The base issue size is ₹100 crore with a green shoe option of ₹50 crore, totaling up to ₹150 crore. These instruments offer a monthly coupon of 10.15% per annum and have a tenure of 30 months. The funds raised will likely support the company's microfinance lending operations and liquidity management.

Ddev Plastiks is diversifying into the Battery Energy Storage System (BESS) sector with a multi-phase manufacturing program. The company plans to establish a 5 GWh facility by FY 2026-27 with an initial capital outlay of ₹150-200 crores. This strategic move targets the growing renewable energy storage market in India, which is projected to reach a market value of USD 32 billion by 2030. Revenue from this new segment is expected to commence in the second half of FY 2026-27.

Thirumalai Chemicals' US subsidiary, TCL Specialties LLC, has commenced the first phase of commercial operations at its new manufacturing facility with the first sale of Maleic Anhydride (MAN). The facility features a MAN plant with a capacity of 40,500 tons per year and a food ingredients plant with over 30,000 tons per year capacity for Malic and Fumaric acid. The company expects the phased commissioning process to be fully stabilized during the first half of calendar year 2026. This expansion targets underserved markets in the North-Eastern and Mid-West US, providing a significant footprint in the North American specialty chemicals sector.

Bharti Airtel has initiated a postal ballot to formalize significant leadership changes, including the appointment of Mr. Shashwat Sharma as MD & CEO (Airtel India) for a five-year term starting January 1, 2026. Mr. Gopal Vittal will transition to the role of Executive Vice Chairman for a concurrent five-year period. The company also proposes the appointment of former SBI Chairman, Mr. Dinesh Kumar Khara, as an Independent Director. Shareholders will vote on these resolutions and amendments to the company's Memorandum and Articles of Association via e-voting between January 3 and February 1, 2026.

Everest Industries has received a favorable order from the Deputy Commissioner CGST, Ranchi, regarding a previously issued Show Cause Notice. The total tax demand, which originally stood at Rs 56.06 crore including interest and penalties, has been drastically reduced to just Rs 69.10 lakhs. This massive reduction of over Rs 55 crore significantly mitigates a major potential financial liability for the company. The company has expressed its intention to contest the remaining demand of Rs 69.10 lakhs in higher forums.